ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Avicanna Inc

Avicanna Inc (AVCN)

0.255
-0.01
(-3.77%)
終了 2月11日 6:12AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.255
買値
0.25
売値
0.26
出来高
114,305
0.25 日の範囲 0.27
0.20 52 週間の範囲 0.60
時価総額
前日終値
0.265
始値
0.27
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
105,583
発行済株式数
74,953,000
配当利回り
-
PER
-2.14
1 株当たり利益 (EPS)
-0.12
歳入
16.79M
純利益
-8.74M

Avicanna Inc について

セクター
Medicinal Chems,botanicl Pds
業界
Medicinal Chems,botanicl Pds
ウェブサイト
本社
Toronto, Ontario, Can
設立
-
Avicanna Inc is listed in the Medicinal Chems,botanicl Pds sector of the トロント証券取引所 with ticker AVCN. The last closing price for Avicanna was $0.27. Over the last year, Avicanna shares have traded in a share price range of $ 0.20 to $ 0.60.

Avicanna currently has 74,953,000 shares in issue. The market capitalisation of Avicanna is $19.86 million. Avicanna has a price to earnings ratio (PE ratio) of -2.14.

AVCN 最新ニュース

Avicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin Pharma

TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused...

Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company

TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused...

Avicanna Reports Q3 2024

9-month revenue of $18.8 million, representing a 75% increase from 2023. Consolidated Gross Margins of 57%, during Q3 2024. TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna”...

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES...

Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca  

TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development...

Avicanna Announces Repayment of Debentures

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused...

Avicanna Announces Closing of Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES...

Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology

USPTO issues Patent No. US 20230025693A1 (“Patent”) that covers Avicanna’s deep penetrating topicalcannabinoid composition and methods for treating musculoskeletal inflammation and pain TORONTO...

Avicanna Subsidiary Completes Export of Aureus Branded CBG into Denmark

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing...

Avicanna Reports Q2 2024

Q2 2024 revenue of $6.1 million an increase of 85% over Q2 2023Completion of two real world evidence trials on Epidermolysis Bullosa and Musculoskeletal Pain TORONTO, Aug. 14, 2024 (GLOBE...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.005-1.923076923080.260.290.25464600.27499352CS
4-0.065-20.31250.320.3550.251496250.29421044CS
120.00520.250.410.231055830.31038557CS
26-0.08-23.88059701490.3350.450.231360040.32927245CS
52-0.135-34.61538461540.390.60.21366220.34971648CS
156-0.295-53.63636363640.550.640.161007070.34337055CS
260-1.745-87.2522.180.16778830.52954172CS

AVCN - Frequently Asked Questions (FAQ)

What is the current Avicanna share price?
The current share price of Avicanna is $ 0.255
How many Avicanna shares are in issue?
Avicanna has 74,953,000 shares in issue
What is the market cap of Avicanna?
The market capitalisation of Avicanna is CAD 19.86M
What is the 1 year trading range for Avicanna share price?
Avicanna has traded in the range of $ 0.20 to $ 0.60 during the past year
What is the PE ratio of Avicanna?
The price to earnings ratio of Avicanna is -2.14
What is the cash to sales ratio of Avicanna?
The cash to sales ratio of Avicanna is 1.12
What is the reporting currency for Avicanna?
Avicanna reports financial results in CAD
What is the latest annual turnover for Avicanna?
The latest annual turnover of Avicanna is CAD 16.79M
What is the latest annual profit for Avicanna?
The latest annual profit of Avicanna is CAD -8.74M
What is the registered address of Avicanna?
The registered address for Avicanna is 480 UNIVERSITY AVENUE, SUITE 1502, TORONTO, ONTARIO, M5G 1V2
What is the Avicanna website address?
The website address for Avicanna is www.avicanna.com
Which industry sector does Avicanna operate in?
Avicanna operates in the MEDICINAL CHEMS,BOTANICL PDS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NCFNorthcliff Resources Ltd
$ 0.05
(42.86%)
1.68M
ELEFSilver Elephant Mining Corp
$ 0.255
(37.84%)
29.13k
VRTSVertiqal Studios Corporation
$ 0.02
(33.33%)
685k
CNTCentury Global Commodities Corporation
$ 0.03
(20.00%)
90k
FLNTFlint Corporation
$ 0.03
(20.00%)
50k
MPVDMountain Province Diamonds Inc
$ 0.06
(-20.00%)
758.77k
WLLWWillow Biosciences Inc
$ 0.025
(-16.67%)
271.67k
RTGRTG Mining Inc
$ 0.025
(-16.67%)
3.16k
TTNMTitanium Transportation Group Inc
$ 1.78
(-14.83%)
240.26k
NPKVerde Agritech Ltd
$ 0.75
(-12.79%)
86.75k
SUSuncor Energy Inc
$ 56.56
(2.20%)
15.98M
TDToronto Dominion Bank
$ 86.01
(3.86%)
14.78M
MFCManulife Financial Corporation
$ 42.73
(-0.77%)
14.57M
ENBEnbridge Inc
$ 64.12
(0.96%)
12.3M
BTEBaytex Energy Corp
$ 3.67
(5.46%)
6.85M

最近閲覧した銘柄

Delayed Upgrade Clock